SHSE:688336 (China)
Â
Class A
Â¥
27.14
+0.26 (+0.97%)
Apr 11
What is a stock summary page? Click here for an overview.
Business Description
Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd
ISIN : CNE1000062X2
Share Class Description:
SHSE:688336: Class ACompare
Compare
Traded in other countries / regions
688336.China Index Membership
SSE Composite Index IPO Date
2020-07-22Description
Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd is a biopharmaceutical company providing safe and effective clinical solutions for the treatment of major diseases such as autoimmune diseases and tumors. The company engages in in research and development, manufacturing and commercialization of therapeutic antibody drugs in China. Its products portfolio includes YISAIPU and Xenopax. Its products in pipeline include 302H, 304R, 602, 601A, 609A and 301S.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 27.39 | |||||
| Equity-to-Asset | 0.93 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.07 | |||||
| Interest Coverage | 213.11 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 24.84 | |||||
| Beneish M-Score | -1.94 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.8 | |||||
| 3-Year EBITDA Growth Rate | 136 | |||||
| 3-Year Book Growth Rate | 7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 17.6 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 16.16 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.88 | |||||
| 9-Day RSI | 51.65 | |||||
| 14-Day RSI | 52.11 | |||||
| 3-1 Month Momentum % | 37.32 | |||||
| 6-1 Month Momentum % | 26.57 | |||||
| 12-1 Month Momentum % | 24.61 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.39 | |||||
| Quick Ratio | 7.67 | |||||
| Cash Ratio | 4.32 | |||||
| Days Inventory | 248.37 | |||||
| Days Sales Outstanding | 49.19 | |||||
| Days Payable | 36.49 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.31 | |||||
| Dividend Payout Ratio | 0.08 | |||||
| Forward Dividend Yield % | 0.31 | |||||
| 5-Year Yield-on-Cost % | 0.32 | |||||
| Shareholder Yield % | 0.33 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 74.5 | |||||
| Operating Margin % | 21 | |||||
| Net Margin % | 59.03 | |||||
| FCF Margin % | 0.03 | |||||
| ROE % | 13.81 | |||||
| ROA % | 12.6 | |||||
| ROIC % | 6.23 | |||||
| 3-Year ROIIC % | 12.13 | |||||
| ROC (Joel Greenblatt) % | 32.62 | |||||
| ROCE % | 13.65 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 23.81 | |||||
| Forward PE Ratio | 54.61 | |||||
| PE Ratio without NRI | 24.61 | |||||
| Shiller PE Ratio | 77.54 | |||||
| Price-to-Owner-Earnings | 36.97 | |||||
| PS Ratio | 14.05 | |||||
| PB Ratio | 3.01 | |||||
| Price-to-Tangible-Book | 3.27 | |||||
| Price-to-Free-Cash-Flow | 13570 | |||||
| Price-to-Operating-Cash-Flow | 59.65 | |||||
| EV-to-EBIT | 21.48 | |||||
| EV-to-EBITDA | 21.48 | |||||
| EV-to-Revenue | 12.76 | |||||
| EV-to-FCF | 40064.98 | |||||
| Price-to-GF-Value | 1.15 | |||||
| Price-to-Projected-FCF | 4.03 | |||||
| Price-to-Graham-Number | 1.89 | |||||
| Price-to-Net-Current-Asset-Value | 7.4 | |||||
| Price-to-Net-Cash | 17.18 | |||||
| Earnings Yield (Greenblatt) % | 4.66 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,193.569 | ||
| EPS (TTM) (Â¥) | 1.14 | ||
| Beta | 1.63 | ||
| 3-Year Sharpe Ratio | 0.46 | ||
| 3-Year Sortino Ratio | 0.79 | ||
| Volatility % | 42.53 | ||
| 14-Day RSI | 52.11 | ||
| 14-Day ATR (Â¥) | 1.496903 | ||
| 20-Day SMA (Â¥) | 27.4865 | ||
| 12-1 Month Momentum % | 24.61 | ||
| 52-Week Range (Â¥) | 15.22 - 30.3 | ||
| Shares Outstanding (Mil) | 616.79 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd Frequently Asked Questions
What is Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd(SHSE:688336)'s stock price today?
The current price of SHSE:688336 is ¥27.14. The 52 week high of SHSE:688336 is ¥30.30 and 52 week low is ¥15.22.
When is next earnings date of Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd(SHSE:688336)?
The next earnings date of Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd(SHSE:688336) is .
Does Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd(SHSE:688336) pay dividends? If so, how much?
The Dividend Yield %  of Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd(SHSE:688336) is 0.31% (As of Today), Highest Dividend Payout Ratio of Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd(SHSE:688336) was 0.21. The lowest was 0.08. And the median was 0.21. The  Forward Dividend Yield % of Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd(SHSE:688336) is 0.31%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers